Fund
Regeneron Ventures
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 1
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 11 August 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 11 Aug | United States, Biotech | Series A | 75 M$ | Lead |
| 28 Apr | Belgium, Biotech | Series A | 125 M$ | Participant |
Co investors 19 funds crossed
- Balyasny Asset Management 1 operation
- Civilization Ventures 1 operation
- Everbright Biofund 1 operation
- Finchley Healthcare Ventures 1 operation
- Forbion 1 operation
- Forge Life Science Partners 1 operation
- Galapagos 1 operation
- Godfrey Capital 1 operation
- Goldcrest Capital 1 operation
- Longwood Fund 1 operation
- Luma Group 1 operation
- Merck Global Health Innovation Fund 1 operation
- Novo Holdings 1 operation
- Pear VC 1 operation
- Playground Global 1 operation
- RA Capital Management 1 operation
- Samsara BioCapital 1 operation
- Sofinnova Investments 1 operation
- Wild Tree Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Belgium.